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CASE REPORT
ABSTRACT:
Malignant parotid tumors are uncommon tumors. Although pleomorphic adenoma is the commonest benign tumor of the parotid accounting for 65%
of tumors but malignant tumors are also seen frequently in parotid gland. Normally these tumors are slow growing  with a long history of lump in
the parotid gland. The rapid growth phase in these tumors indicate malignant transformation. The involvement of facial nerve is a late symptom and
denote advance stage.  We are presenting a giant malignant tumor of the parotid gland measuring 22cm x 15cm in a lady of 50 years. To the best of
our knowledge this is the biggest tumor reported so far in Pakistan.
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INTRODUCTION:
Most textbooks suggest that one in six parotid tumors
are malignant. Some even quote  higher figure. Tumors
enlarge laterally producing a visible swelling. Malignant
tumors may enlarge rapidly and facial nerve involvement
is not uncommon. Carcinomas of deep lobe expand
medially into the pharynx producing bulge and pushing
tonsil and pharynx medially. The surgical anatomy of
the parotid gland is complex, with the facial nerve growing
through it dividing the gland into two unequal parts. Thus
the concept of a superficial and a deep lobe is purely one
of surgical anatomy. The commonest malignancy is the
mucoepidermoid carcinoma followed by adenoid cystic
carcinoma.
CASE REPORT:
We are presenting a case of Rashida Begum, a 50 year
old female,who attended outpatient department of
AbbasiShaheed Hospital with a huge mass right side of
face, bleeding at places with multiple skin breeches. The
patient was severelyanaemic and in pain. The history
was long about 18 to 20 years. On clinical examination
a giant, irregularly shaped, mulilobulated, mobile,
fungating, bleeding tumor on right side of face was noted
arising from parotid and hanging down onto the neck.
The mass measured 22cm by 15 cm. The facial nerve
was intact.
There was a previous history of surgery for a mass in
right parotid area long ago. The patient had lost all the
relevant record and only remembers that it was not a
malignant tumor. Following that surgery, the patient
remained symptom free for about ten years. Then she
developed a small mass in the same area which gradually
increased to this huge size in about six years.The bleeding
from the mass about fourmonths ago months ago and
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 pain about two months ago.
When the patient was seen in outpatient, she was severely
anaemic with a Hb. of 2.7gms only. She was given
multiple packed cell transfusions to raise the Hb. Along
with high caloric diet. All other laboratory investigations
were within normal limits.
C.T. scan revealed a tumor, 22cm by 15 cm, multi
lobulated arising from right parotid area, involving the
submandibular area, paraphryngeal space and abutting
the paravertebral muscles and carotids with a fat plan in
between. A large postauricular mass seen projecting from
the main mass. Contrast C.T. showed enhancement
showing high vascularity with large vessels entering the
mass from the periphery.
Clinically the mass was mobile and not fixed to the
deeper tissues. There was no intraoral extension or bulge,
indicating that the tumor was arising from superficial
part of the parotid. Larynx was within normal limits and
there was no swallowing difficulty. The facial nerve was
intact.
Multiple biopsies were taken and sent for histopathology
which confirms it to a highly suspicious adenoid cystic
carcinoma. As the adenoid cystic carcinoma spread
through the peripheral nerves, the consent of the patient
was taken for sacrifice of facial nerve. A total
parotidectomy including facial nerve was done removing
the skin involved with two cm safe margins.
DISCUSSION:
There is no universally agreed classification exists but




•  Non epithelial tumors
•  Malignant melanoma
•  Secondary tumors
•  Unclassified tumors
If we look at malignant tumors, following histological
types are seen in parotid gland.
1.  Acinic cell carcinomas
2.  Mucoepidermoid carcinomas
3.  Adenoid cystic carcinomas
4.  Polymorphous low grade adenocarcinomas
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5.   Papillary cystadenocarcinoma
6.   Mucinous adenocarcinomas
7.   Carcinoma expleomorphic adenoma
8.   Malignant mixed tumors
9.   Squamous cell carcinomas
10. Undifferentiated carcinomas
Fig 1a: Bleeding tumor on right side of face
Fig 2a: CT SCAN
Fig 1b :Multi lobulated fungating tumor of parotid gland
Acinic cell carcinoma is regarded as low grade malignancy
and account for 15% of parotid malignancies. It gives
the best survival rate for any salivary tumor and so facial
nerve should be preserved at all cost. There is no
justification for sacrifice of facial nerve in acinic cell
carcinomas.
Mucoepidermoid carcinomas are the most common
malignant tumors of parotid, and can be classified as low
grade anf high grade. Low grades tend to be cystic while
high grade tends to be solid in consistency, with areas of
necrosis and heamorhage. In high grade tumors, lymph
node metastasis occurs in three quarters of cases. So in
high grade tumors a total parotidectomy is performed
with neck dissection. Facial nerve can be spared if not
involved.
Adenoid cystic is the most notorious malignancy and
41% are locally advanced at the time of presentation,
with 11% having distant metastasis. This tumor is said
to be never cured and the recurrence rate at 30 years is
almost 100%. Lung metastasis is characteristic of this
tumor. These tumors have a predisposition to invade and
spread along the peripheral nerves and for this reason
facial nerve is sacrificed with the tumor resection.
CONCLUSION:
Giant malignant tumors of the parotid are a rare entity
and only few cases of this enormous size had been
reported in world literature. The lack of proper medical
facilities, lack of knowledge and negligence are the
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